SEC Form 4 · accession 0001144204-16-126850
MEDIFAST INC · MED
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel R Chard
Officer — Chief Executive Officer · Director
Period of report
Oct 3, 2016
Accepted (ET)
Oct 4, 2016 · 6:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000910329
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 3, 2016 | A | 16,061 | $0.00 | A | 16,061 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Performance-based deferred sharesF2 | — | Oct 3, 2016 | A | 210,000 | A | — | Dec 31, 2019 | Common Stock | 210,000 | 210,000 | D |
Explanation of responses
- F1These shares will vest one-third per year on each of the first, second and third anniversaries of the grant date.
- F2Represents the maximum number of shares that may be earned under this performance-based deferred share award. The actual number of deferred shares that will vest will be determined based on the achievement of certain pre-established performance goals, including the Company's total shareholder return and the price of the Common Stock.